Replies to post #2064 on RADIO SILENT PLAY STOCK PICKS $$$

[Aquahoya]

$MILV

His patents and prior research on liposomal carrier nanoparticles will be used for any and everything. Once the drug is developed (either "water loving" or "or "water hating"), they can be added to the liposome and the liposome targeted to region of interest.


Some of the recent published works that cited Michael W. Fountain utilizing his Liposome technology/research that he helped pioneer.

http://emedicalj.com/en/articles/55892.html (Vaccine, 2015)

https://link.springer.com/article/10.1007/s00430-017-0524-z (Whooping Cough, 2018)

https://www.ingentaconnect.com/content/ben/cnano/2011/00000007/00000003/art00022 (Targeting Strategy, 2011)

https://www.sciencedirect.com/science/article/pii/S016836591400337X (Antimicrobial Agents, 2014)

https://www.futuremedicine.com/doi/full/10.2217/nnm.15.128 (Treatment towards intracellular bacterial infections, 2015)

http://digitalcommons.lsu.edu/cgi/viewcontent.cgi?article=2820&context=gradschool_theses (Silver and Gold Nanopart, 2013)

http://www.dl.begellhouse.com/download/article/7c2005db111a1ed6/CRT4063_final.pdf (Cancer Chemotherapy, 2012)

https://www.sciencedirect.com/science/article/pii/S0168365915005830
https://www.future-science.com/doi/full/10.4155/fmc.15.35
http://diposit.ub.edu/dspace/handle/2445/99607
(Antimalaria prophylactic, 2015)

https://www.sciencedirect.com/science/article/pii/S0168365916306873 (Infected-red blood cells, 2016)

https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/281584/TOC (Liposome Stability and Interaction, 2018)